| HS Code | 986442 |
| Chemical Name | ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
| Molecular Formula | C30H28N6O3 |
| Appearance | solid |
| Solubility | DMSO, DMF |
| Purity | ≥98% |
| Storage Temperature | 2-8°C (refrigerated) |
| Smiles | CCOC(=O)CCNC(=O)c1ccc2nc([nH]c2c1)CNC3=CC=C(C#N)C=C3NC4=CC=CC=N4 |
As an accredited ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is supplied in a 5g amber glass vial with a screw cap, labeled with name, quantity, and safety information. |
| Container Loading (20′ FCL) | 20′ FCL (Full Container Load) accommodates about 10–12 metric tons of ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate, packed securely in drums or cartons. |
| Shipping | The chemical **ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate** is shipped in securely sealed containers, protected from light, heat, and moisture. It is transported according to standard chemical safety regulations, with appropriate labeling and documentation for safe handling. Expedited, trackable delivery ensures product integrity. |
| Storage | Store **ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate** in a tightly sealed container, protected from light and moisture. Keep at 2–8°C in a dry, well-ventilated area. Ensure compatibility with surrounding chemicals and avoid sources of ignition. Clearly label and restrict access to qualified personnel, following all relevant safety protocols and regulations. |
| Shelf Life | Shelf life: Store at 2–8°C, tightly sealed; stable for at least 2 years under recommended conditions, protected from light and moisture. |
As a specialized manufacturer, we supply ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate to advanced sectors requiring precision intermediates for synthesis. Our facility supports downstream manufacturers across regulated industries where high molecular specificity, purity consistency, and regulatory alignment are critical to final product quality and compliance. Below, we outline core industrial pathways where this intermediate acts as a building block, specifying compliance, usage, process stage, and finished formats for each.
Leading pharmaceutical producers employ this compound in multi-step syntheses for targeted small molecule active pharmaceutical ingredients (APIs) in oncology, particularly where benzimidazole derivatives function as kinase inhibitors or DNA intercalators. Our material enters the sequence as a late-stage intermediate, facilitating substitution and condensation reactions for final API core formation, with process impurity control and reproducible batch quality central for GMP-compliant drug substance output.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Agrochemical companies rely on this raw material as a precursor for benzimidazole-based herbicide manufacture, exploiting its multifunctional side groups for downstream chlorination or methylation reactions. Integrating at the laboratory scale and pilot production stages, formulators precisely control its input to achieve selective weed control active compounds, subject to agricultural regulation and environmental discharge monitoring.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
The electronics and display materials industry integrates this compound as a functionalized intermediate for organic light-emitting diode (OLED) material synthesis, leveraging its rigid aromatic and heterocyclic elements for emissive layer precursor design. Downstream companies demand high chemical consistency and analytical validation due to device sensitivity and stability specs.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Contract laboratories and reagent producers incorporate this benzimidazole ester as a key intermediate during the manufacture of advanced detection chemistries, notably high-specificity fluorescent markers and bioconjugation agents for research and diagnostics. Exact addition rates adjust based on functional labeling density, and product quality adheres to analytical and purity certifications for trace impurity control.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Competitive ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8618005193850
Email: sales8@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Every year, research requirements bring a batch of new challenges to the lab bench. Ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate has found an important role in those challenges, not as another generic material, but because of the complexity and selectivity built into its molecular skeleton. Years of process development, in both discovery and scale-up, taught us a hard truth—design alone isn’t enough. Synthesis must deliver reproducibility, stability, and purity.
This compound pushes well past “off-the-shelf” intermediates. The mixture of a benzimidazole core, substituted with pyridinyl and cyanophenyl groups, paired with a propanoate ester tail, gives researchers tools that pure simplicity can’t match. That unique profile means applications often go beyond small-scale, academic tests. As a chemical manufacturer, we spend a fair share of our time refining the route, running trial batches to ensure every gram matches expectations. Batch-to-batch consistency doesn’t come from luck—it’s the sum of years of process work.
Scaling up a molecule with this level of functional diversity tested our plant in ways basic intermediates never did. For instance, managing the step where we introduce the cyanophenylamine unit proved sensitive to both solvent quality and temperature ramp rates. Inconsistency creeps in easily. Lessons learned led us to switch to custom jacketed reactors with digital feedback. You know you’ve got the process under control when each batch walks into HPLC analysis and the peaks land exactly where you expect, at the purities you worked to reach.
We don’t just throw this product into inventory and forget it; every release batch involves wet chem tests, spectroscopy checks, and stability monitoring in multiple storage conditions. Those checks aren’t formalities. Years ago, when a shipment went through unexpected warehouse cycles in a tropical port, an accelerated shelf-life study flagged a breakdown risk. We adjusted drying steps and stuck to cold-chain handoffs, from final filtration right to our clients’ glassware. Not everyone catches those details when the order book is full.
Within pharmaceutical and fine chemical research, molecules with this arrangement of benzimidazole and bifunctional side chains often end up as key building blocks for lead optimization. They show up in heterocyclic chemistry, fragment-based drug design, or in the assembly of probe molecules within medicinal chemistry teams. We’ve seen projects where this propanoate ester gets selectively hydrolyzed, swapped for bioisosteres, or even carried through protection and deprotection schemes.
Beyond that, its structure—with a benzimidazole backbone—has earned a place in a few advanced materials and agrochemical discovery programs. Not every route leads to a blockbuster drug; sometimes the molecule opens doors to entirely new SAR explorations, or it offers solubility tweaks other intermediates can’t provide. Customers have fed back that our process gives them fewer byproducts in their downstream reactions, which lets them focus on innovation, not troubleshooting synthesis problems.
Working directly with medicinal chemists and project leads, we see subtle patterns. They don’t pick this compound at random; they pick it for programmability, stability under a variety of workup conditions, and the possibility of clean functional group transformations. Our technical support gets questions ranging from optimal saponification conditions to strategies for downstream amidation. Each of those questions becomes fuel for process improvement on our end.
In crowded fine chemical supply chains, many suppliers act as middlemen. As a manufacturer, we start with actual kilogram-scale, in-house synthesis. It makes a difference. Developing a route that stably introduces the 4-cyanophenyl group into the amine required careful selection of reductive amination conditions. Some literature procedures get you to the product, but you wind up with secondary impurities that make purification a headache. We dialed in a protocol—solid phase filtration at just the right point, pressure and temperature profiles that work at full scale—and those tweaks kept side reactions to a minimum.
Unlike simpler benzimidazole derivatives, this product’s side groups mean it’s more than a basic core modifier. That translates to more versatile SAR work and higher value in synthesis schemes, especially where steric and electronic modulations change the profile of a drug candidate or advanced intermediate. The presence of both pyridine and benzimidazole rings, each with electron-donating and electron-withdrawing neighbors, offer more knobs to tune in drug design than you’d get from single-core intermediates.
Spec sheets never capture the day-to-day grind of plant chemistry. Our ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate typically ships as an off-white to pale yellow solid, with purity standards driven upward not by marketing, but by the needs of LC/MS quant methods and downstream protection/deprotection chemistry.
Moisture spec matters more here than in commodity esters. Some reaction routes hate the trace water that creeps in from humid storage or long shipping times. We spent months wrestling with drying protocols and packaging systems until QC no longer flagged outliers. Every shipment that lands at a customer’s facility has not only cleared static purity and identity tests, but also stability studies under typical bench and cold-room conditions.
Process chemistry grows up where lab-scale convenience and industrial execution collide. Customers with tough analytical requirements sometimes share their LC/MS chromatograms. Each time, we map their feedback to process tweaks: cleaner separation, solvent selection, or even minor changes in work-up. Constant communication exposed occasional blips. Some batches once showed stubborn trace byproducts, traced back to a vendor change upstream. We fixed that through tighter in-house purification, tracked every barrel of incoming material with more aggressive supplier auditing, and it paid off—the error rate fell, and clients noticed.
Supply chain headaches never disappear, but deep roots in synthesis—handling our own raw materials, making every reaction step reproducible, obsessively logging every kilo—lets us control quality at a level short supply lines never match. One early lesson: Never trust that a “good enough” lab-scale procedure will play nice at 10x or 100x scale. Real yield and reproducibility only come after a string of pilot-scale headaches and sleepless nights. Every hiccup is a checkpoint; every clear, high-purity batch feels like proof of that learning process.
With a chemotype as elaborate as this, the difference between a 96% pure product and one that just flirts with 98% isn’t trivial. Downstream reactions don’t shrug off those last impurity percentiles. Failure feeds forward as extra column time, more work-ups, or ruined end products. By tuning synthetic routes—in one case, adding two-point monitoring for a key condensation step—we pulled impurity profiles down to where results speak for themselves.
Each side chain, particularly the pyridin-2-yl and cyanophenyl groups, brings its own quirks in terms of reactivity and side-product formation. The methyl group on the benzimidazole not only modifies electronics for downstream coupling but also creates a tighter window for reaction control. Staff have stories of subtle pH drifts in aqueous work-ups or temperature ramps, causing byproduct spikes until we figured out better controls.
It’s tempting to lump this category of molecules with other benzimidazole-based intermediates. Pulling from years of supplying both simpler and more complex analogs, the key distinction here revolves around the interplay of side-chain functionality and the stability of the ester moiety. Other benzimidazole intermediates bring utility, but without the same spectrum of reactivity or compatibility with medicinal and discovery chemistry platforms.
Some customers ask if off-the-shelf benzimidazole esters could do the job. Those alternatives often fall down during late-stage modifications or purification, due to less optimized side chains or lower solubility profiles. The fit with solvent windows—from DMSO to more polar protic environments—is stronger here. Projects that once needed several clean-up steps benefit from a route featuring this intermediate, skipping headaches with less predictable analogs.
Our packaging team works side by side with technical leads to make sure that, when a researcher opens a drum or sample vial, material comes out exactly as it left our QC lab. This doesn’t mean fancy packaging; it means seals that prevent moisture pickup, containers that don’t leach trace contaminants, and instructions grounded in hands-on lab experience.
Customers with critical timelines get material that has spent less time on loading docks and more time in environmentally controlled storage. Our logistics team and documentation backstops these promises with temperature logs, chain-of-custody records, and clear stability summaries. Scientists know how lost days carve holes in project budgets, and we do, too. The reality of scale-up means a missed window throws off an entire synthesis schedule. That feedback, directly from the field, stays front and center in how we plan production, down to how we stagger batch releases and buffer stock.
Sometimes a customer’s synthetic plan takes a sharp turn—they suddenly need a variant, extra purification, or batch-matched technical support. We’ve built surge production and tech transfer teams who can launch tailored campaigns within days, not weeks. Whether it’s a custom impurity profile, support for process verification, or alternate packaging sizes, we’ve learned that agility sets a manufacturer apart. Working hip-to-hip with R&D and process teams, not just selling bulk jars, draws a more honest line between us and distant or drop-shipping suppliers.
It’s easy to overlook how much end-user feedback changes how a product like this evolves. We don’t set and forget specifications. Instead, every intake from a client—whether it’s a yield stumble, a new analytical peak, or an unexpected handling quirk—drives one more round of experimentation on our side. As a result, what leaves our facility today stands on the shoulders of real-world, real-lab interactions.
This isn’t just about customer satisfaction. Every analytical scan, every shipped kilogram, and every synthetic route explored adds to the feedback loop. Our chemists thrive on the fine details. A competing product might claim a similar benzimidazole ester core, but actual chemical genealogy rarely matches. Over years, tracking development from pilot runs to metric tons, we’ve found that proper investment in analytical controls, feedback testing, and line-driven tweaks lead to both stronger client relationships and more reliable chemistry at the bench.
There’s a lot of noise in custom synthesis these days. Experience, not marketing language, keeps projects moving. Every order, from tens of grams for an early-stage program to larger lots for advanced candidates, gets personal oversight from a production team that’s seen every glitch chemical manufacturing can toss at them. Surprises happen—solvent rushes, vendor switches, transportation snags—but tight process integration means we catch them quickly.
Our plant thrives because the plant leadership has backgrounds in bench chemistry, scale-up, and supply planning. Lines of communication run directly from the R&D nerds who write the procedures to the operators who monitor reaction exotherms and vacuum integrity at 2 AM. No detail gets brushed aside as “someone else’s problem.”
The story of ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate belongs as much to our clients as to us. We watch it move through fragment libraries, get chopped and stitched into new analogs, and sometimes serve as a reference for analytical development. Its use evolves with the changing face of synthesis, and our job stays fixed: remove manufacturing friction, deliver confidence.
We know the impact that process improvements, precise control, and hands-on support have for downstream innovation. It’s not just about getting another product onto a catalog page. It’s about backing every shipment with knowledge shaped by real runs, real setbacks, and real solutions. Our clients turn this molecule into the next advances in chemistry and biology—and we’re here, every step, making sure nothing holds them back.